Information for RespimatĀ® patients and carers. Are you a healthcare professional? Visit our healthcare professional site

Accessibility Statement for Boehringer Ingelheim websites

Boehringer Ingelheim is committed to providing a website that is accessible to the widest possible audience, regardless of technology or ability. We are actively working to increase the accessibility and usability of our website and in doing so adhere to many of the available standards and guidelines. These guidelines explain how to make web content more accessible for people with disabilities. Conformance with these guidelines will help make the internet more user-friendly for all people. We are continually seeking out solutions that will bring all areas of the Site up to the same level of overall web accessibility.

We try to offer a clear navigation structure that helps you to find the content you are looking for in an easy and quick way.

Links contain title attributes that describe the content and make sense out of context.

The use of short sentences and paragraphs and multiple entries points to additional information sources.

In the meantime, should you experience any difficulty in accessing the Boehringer Ingelheim website, please do not hesitate to contact us.

Please note that this website is designed for information and reference purposes only. It is not intended to replace the advice of a healthcare professional. You should consult your doctor or another suitably trained healthcare professional if you have any questions or concerns regarding your health conditions or medications, and report any side effects to them immediately.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via The Yellow Card Scheme at www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
NP-GB-100348 V3 - July 2021